Likewise, METTL3- and METTL14-mediated m6A modification of LncAROD enhanced its stability and promoted ternary complex formation with HSPA1A and YBX1, driving progression in head and neck squamous cell carcinoma (35). Here, METTL14 is linked to head and neck squamous cell carcinoma.